Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
adalimumab (humira) (1 trial)
naltrexone (revia) (1 trial)
Arthritis (Phase 4)
Trials (1 total)
Trial APIs (2 total)